Literature DB >> 25547617

Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.

Geoffrey K Broadhead1, Andrew Chang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547617     DOI: 10.1007/s00417-014-2891-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  Central serous chorioretinopathy: a personal perspective.

Authors:  Lawrence A Yannuzzi
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

2.  Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration.

Authors:  Nishant Kumar; Marcela Marsiglia; Sarah Mrejen; Adrian Tien-Chin Fung; Jason Slakter; John Sorenson; K Bailey Freund
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

3.  Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathy.

Authors:  Joseph Pikkel; Shimon Rumelt
Journal:  Eur J Ophthalmol       Date:  2012 May-Jun       Impact factor: 2.597

4.  Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.

Authors:  Lazaros Konstantinidis; Irmela Mantel; Leonidas Zografos; Aude Ambresin
Journal:  Eur J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 2.597

5.  Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Authors:  Andrew A Chang; Haitao Li; Geoffrey K Broadhead; Thomas Hong; Timothy E Schlub; Wijeyanthy Wijeyakumar; Meidong Zhu
Journal:  Ophthalmology       Date:  2013-10-18       Impact factor: 12.079

6.  Cystoid macular degeneration in chronic central serous chorioretinopathy.

Authors:  Tomohiro Iida; Lawrence A Yannuzzi; Richard F Spaide; Natalie Borodoker; Cynthia A Carvalho; Silvana Negrao
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

7.  Factors influencing the visual acuity of chronic central serous chorioretinopathy.

Authors:  Yun Young Kim; Christina J Flaxel
Journal:  Korean J Ophthalmol       Date:  2011-03-11
  7 in total
  2 in total

1.  Clinical efficacy of intravitreal corticoid as an adjunctive therapy to anti-VEGF treatment of neovascular age-related macular degeneration: a Meta-analysis.

Authors:  Bo-Hao Cui; Wei Zhou; Wen-Wen Wang; Hao Yang; Ya-Lan Dong; Yuan-Yuan Liu; Hua Yan
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

2.  Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy.

Authors:  Ga-In Lee; A Young Kim; Se Woong Kang; Soo Chang Cho; Kyu Hyung Park; Sang Jin Kim; Kyung Tae Kim
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.